Mauritskliniek intends to join Corius

Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. Corius is the largest network of dermatology and phlebology practices in Germany and Switzerland.

By acquiring Mauritskliniek, Corius geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of  Corius.

Mauritskliniek intends to join Corius in the third quarter of 2022, after potential approval of the  Nederlandse Zorgautoriteit (NZa).

About Corius

Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. Corius offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. Corius has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de

About Mauritskliniek

Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.6/10 points, according zorgkaartnederland.nl. www.maurtiskliniek.nl

About Holland Capital

Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.

Quantib has been acquired by RadNet

Quantib has been acquired by RadNet ROTTERDAM, January 24, 2022 – Our portfolio company Quantib has been acquired by RadNet, Inc. (NASDQ: RDNT), a US leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network...

AMP Groep joins forces with Delta Logistiek

AMP Groep joins forces with Delta Logistiek  Houten, 10 January 2022 – Our participation AMP is taking the first step in its buy-and-build strategy with Delta Logistiek, enabled by Holland Capital. The joint entity can fully address its customers' needs trough an...

Holland Capital winner at the M&A Awards

Holland Capital winner at the M&A Awards Amsterdam, December 17, 2021 – Holland Capital wins an M&A Award again this year. Last Thursday, the best deals and dealmakers of 2021 were announced. Holland Capital was declared the winner of the six nominated...

Sirius Medical announces second closing of A-round financing

Sirius Medical announces second closing of A-round financingCompany to accelerate U.S. expansion and innovation for next generation tumor navigation technology Eindhoven, Netherlands – December 14, 2021 –  Our portfolio company Sirius Medical, a leader in tumor...

YOEP Onderwijs en Zorg joins forces with Holland Capital

YOEP Onderwijs en Zorg joins forces with Holland Capital Amsterdam, December 3, 2021 – Holland Capital joins forces with YOEP Onderwijs en Zorg, a psychiatric organisation for children and youth that focuses on the interaction between family, education and care. With...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11

 

Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01